fiercepharmaAugust 17, 2017
Tag: Seqirus , Fujifilm , Intellia
> Seqirus executives expect to break even this year and report that the flu vaccine company is on track to profitability.
> Fujifilm Diosynth and Texas A&M University are collaborating as a Center for Innovation in Advanced Development and Manufacturing.
> Flu vaccines were 48% effective overall last year, according to a study published in The New England Journal of Medicine.
> Former GlaxoSmithKline vaccine head Moncef Slaoui resigned from Intellia's board.
> Vaxess, a preclinical vaccine biotech, picked up former Sanofi Pasteur head Wayne Pisano for its advisory board.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: